KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Free Cash Flow (2017 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Free Cash Flow for 18 consecutive years, with $48.7 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 139.26% year-over-year to $48.7 million; the TTM value through Mar 2026 reached $685.8 million, up 1448.93%, while the annual FY2025 figure was $513.2 million, 4924.92% up from the prior year.
  • Free Cash Flow hit $48.7 million in Q1 2026 for Alnylam Pharmaceuticals, down from $188.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $342.3 million in Q3 2023 and bottomed at -$180.4 million in Q1 2023.
  • Average Free Cash Flow over 5 years is $6.2 million, with a median of -$74.9 million recorded in 2023.
  • Year-over-year, Free Cash Flow tumbled 823.53% in 2024 and then soared 567.27% in 2025.
  • Alnylam Pharmaceuticals' Free Cash Flow stood at -$131.0 million in 2022, then surged by 110.15% to $13.3 million in 2023, then crashed by 823.53% to -$96.2 million in 2024, then soared by 295.4% to $188.1 million in 2025, then plummeted by 74.12% to $48.7 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $48.7 million, $188.1 million, and $293.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.